Preimplantation genetic testing for BRCA gene mutation carriers: a cost effectiveness analysis

[1] Wooster R(2003)Breast and ovarian cancer. Guttmacher AE, Collins FS, editors N Engl J Med 348 2339-2347

[2] Weber BL(2003)Taskforce 5: Preimplantation genetic diagnosis Hum Reprod 18 649-651

[3] Shenfield F(2018)BRCA mutations and reproduction Fertil Steril 109 33-38

[4] Pennings G(2017)Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry Am J Obstet Gynecol 217 578.e1-578.e12

[5] Devroey P(2015)Population testing for cancer predisposing BRCA1/BRCA2 mutations in the ashkenazi-jewish community: a randomized controlled trial J Natl Cancer Inst 107 1-11

[6] Sureau C(2018)Reproductive outcome following pre-implantation genetic diagnosis (PGD) in the UK Hum Fertil 21 120-127

[7] Tarlatzis B(2017)ESHRE PGD consortium data collection XIV-XV: cycles from January 2011 to December 2012 with pregnancy follow-up to October 2013 Hum Reprod 32 1974-1994

[8] Cohen J(2018)Use of preimplantation genetic testing for monogenic defects (PGT-M) for adult-onset conditions: an ethics committee opinion Fertil Steril 109 989-992

[9] Daum H(2016)Outcomes of in vitro fertilization with preimplantation genetic diagnosis: an analysis of the United States assisted reproductive technology surveillance data, 2011–2012 Fertil Steril 105 394-400

[10] Peretz T(2007)Cost-utility analysis of vaccination against HPV in Israel Vaccine. 25 6677-6691

[1] Wooster R(2003)Breast and ovarian cancer. Guttmacher AE, Collins FS, editors N Engl J Med 348 2339-2347

[2] Weber BL(2003)Taskforce 5: Preimplantation genetic diagnosis Hum Reprod 18 649-651

[3] Shenfield F(2018)BRCA mutations and reproduction Fertil Steril 109 33-38

[4] Pennings G(2017)Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry Am J Obstet Gynecol 217 578.e1-578.e12

[5] Devroey P(2015)Population testing for cancer predisposing BRCA1/BRCA2 mutations in the ashkenazi-jewish community: a randomized controlled trial J Natl Cancer Inst 107 1-11

[6] Sureau C(2018)Reproductive outcome following pre-implantation genetic diagnosis (PGD) in the UK Hum Fertil 21 120-127

[7] Tarlatzis B(2017)ESHRE PGD consortium data collection XIV-XV: cycles from January 2011 to December 2012 with pregnancy follow-up to October 2013 Hum Reprod 32 1974-1994

[8] Cohen J(2018)Use of preimplantation genetic testing for monogenic defects (PGT-M) for adult-onset conditions: an ethics committee opinion Fertil Steril 109 989-992

[9] Daum H(2016)Outcomes of in vitro fertilization with preimplantation genetic diagnosis: an analysis of the United States assisted reproductive technology surveillance data, 2011–2012 Fertil Steril 105 394-400

[10] Peretz T(2007)Cost-utility analysis of vaccination against HPV in Israel Vaccine. 25 6677-6691